Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
about
Kynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyMetabolic consequences of interleukin-6 challenge in developing neurons and astrogliaNeuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood.Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderIncreased breakdown of kynurenine towards its neurotoxic branch in bipolar disorderAn altered peripheral IL6 response in major depressive disorderDepressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.Is Toxoplasma gondii a Trigger of Bipolar Disorder?Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.Human dermal fibroblasts in psychiatry research.Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.Serum kynurenic acid is reduced in affective psychosis.Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia.The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing.
P2860
Q26782867-D4DBEE56-B651-4AE1-8917-677E34D6A443Q28397737-BFBA6785-C3BF-4E45-84A3-586EC225D5E7Q34979782-9E117251-A436-4BE7-A52A-1FF0161356A9Q35058307-689F9C93-1163-4094-984B-F90FB867EE3DQ35554351-C5730F13-EBBE-438D-8986-55746C3625ABQ35647362-C23AD51C-F4F2-490D-A85C-72F0490AB477Q36291638-4E13CA75-2E31-43B0-9072-FDC8A78BA873Q36669690-E42182AF-8EEA-400C-9A52-A84AEB7B0E82Q37111098-0084B557-4A8E-4A3C-AC21-3A4FC3F9DB55Q37727986-F631BF23-FF86-4AFC-9C86-B043C5CA9FB3Q38332353-7386C4B0-52A0-4588-AE26-A19DD8F40516Q38726048-D38585B7-C0CC-42F0-8931-761AEE41E737Q38843539-EEF289B1-D0DF-4FA3-AAD2-5C46E16C2C03Q38919287-C34C65D0-4C70-4792-AF37-6B7E7F86A259Q41173215-7A4EE357-B860-4E4C-BD94-3B6A70601050Q42291040-8ACC9331-390D-432C-AC99-D130A1DDFD55Q43170816-588F1804-3184-4C4F-A604-729F703BB48A
P2860
Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Activation of kynurenine pathw ...... uction of 3-hydroxykynurenine.
@en
Activation of kynurenine pathw ...... uction of 3-hydroxykynurenine.
@nl
type
label
Activation of kynurenine pathw ...... uction of 3-hydroxykynurenine.
@en
Activation of kynurenine pathw ...... uction of 3-hydroxykynurenine.
@nl
prefLabel
Activation of kynurenine pathw ...... uction of 3-hydroxykynurenine.
@en
Activation of kynurenine pathw ...... uction of 3-hydroxykynurenine.
@nl
P2093
P50
P1476
Activation of kynurenine pathw ...... duction of 3-hydroxykynurenine
@en
P2093
Anne-Sofie Johansson
Björn Owe-Larsson
Jerker Hetta
Linnéa Asp
Mats Adler
P304
P356
10.1016/J.JPSYCHIRES.2013.08.008
P577
2013-08-23T00:00:00Z